BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12406399)

  • 21. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician.
    Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P
    Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome.
    Frebourg T; Barbier N; Yan YX; Garber JE; Dreyfus M; Fraumeni J; Li FP; Friend SH
    Am J Hum Genet; 1995 Mar; 56(3):608-15. PubMed ID: 7887414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial gastric cancer and Li-Fraumeni syndrome.
    Corso G; Pedrazzani C; Marrelli D; Pinto E; Roviello F
    Eur J Cancer Care (Engl); 2010 May; 19(3):377-81. PubMed ID: 19674071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel TP53 mutations in familial and sporadic cancer cases of German and Swiss origin.
    Bendig I; Mohr N; Kramer F; Weber BH
    Cancer Genet Cytogenet; 2004 Oct; 154(1):22-6. PubMed ID: 15381368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
    Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
    Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal diagnosis in Li-Fraumeni syndrome.
    Avigad S; Peleg D; Barel D; Benyaminy H; Ben-Baruch N; Taub E; Shohat M; Goshen Y; Cohen IJ; Yaniv I; Zaizov R
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):541-5. PubMed ID: 15342977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome.
    Evans DG; Birch JM; Thorneycroft M; McGown G; Lalloo F; Varley JM
    J Med Genet; 2002 Dec; 39(12):941-4. PubMed ID: 12471212
    [No Abstract]   [Full Text] [Related]  

  • 28. Three germline mutations in the TP53 gene.
    Cornelis RS; van Vliet M; van de Vijver MJ; Vasen HF; Voute PA; Top B; Khan PM; Devilee P; Cornelisse CJ
    Hum Mutat; 1997; 9(2):157-63. PubMed ID: 9067756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Li Fraumeni syndrome: a case with multiple primary cancers and presenting a germline p53 mutation].
    Landolsi S; Gharbi O; Zrig M; Gribaa M; Njim L; Zakhama A; Abid A; Frébourg T; Ahmed SB
    Ann Biol Clin (Paris); 2010; 68(3):346-50. PubMed ID: 20478780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours.
    Sedlacek Z; Kodet R; Kriz V; Seemanova E; Vodvarka P; Wilgenbus P; Mares J; Poustka A; Goetz P
    Br J Cancer; 1998 Apr; 77(7):1034-9. PubMed ID: 9569035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.
    Kappel S; Janschek E; Wolf B; Rudas M; Teleky B; Jakesz R; Kandioler D
    Breast Cancer Res Treat; 2015 Jun; 151(3):671-8. PubMed ID: 25981898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germ-line TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2.
    Huusko P; Castrén K; Launonen V; Soini Y; Pääkkönen K; Leisti J; Vähäkangas K; Winqvist R
    Cancer Genet Cytogenet; 1999 Jul; 112(1):9-14. PubMed ID: 10432928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The first pancreatic neuroendocrine tumor in Li-Fraumeni syndrome: a case report.
    Aversa JG; De Abreu FB; Yano S; Xi L; Hadley DW; Manoli I; Raffeld M; Sadowski SM; Nilubol N
    BMC Cancer; 2020 Mar; 20(1):256. PubMed ID: 32228502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of TP53 germline mutations in pediatric tumor patients using DNA microarray-based sequencing technology.
    Schaefer KL; Wai D; Poremba C; Diallo R; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2002 Apr; 38(4):247-53. PubMed ID: 11920788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
    J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of germline TP53 mutations and history of Li-Fraumeni syndrome in families with childhood adrenocortical tumors, choroid plexus tumors, and rhabdomyosarcoma: a population-based survey.
    Magnusson S; Gisselsson D; Wiebe T; Kristoffersson U; Borg Å; Olsson H
    Pediatr Blood Cancer; 2012 Nov; 59(5):846-53. PubMed ID: 22653678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A TP53-truncating germline mutation (E287X) in a family with characteristics of both hereditary diffuse gastric cancer and Li-Fraumeni syndrome.
    Kim IJ; Kang HC; Shin Y; Park HW; Jang SG; Han SY; Lim SK; Lee MR; Chang HJ; Ku JL; Yang HK; Park JG
    J Hum Genet; 2004; 49(11):591-595. PubMed ID: 15368100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further evidence for pathogenicity of the TP53 tetramerization domain mutation p.Arg342Pro in Li-Fraumeni syndrome.
    Etzold A; Schröder JC; Bartsch O; Zechner U; Galetzka D
    Fam Cancer; 2015 Mar; 14(1):161-5. PubMed ID: 25226867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.
    Villani A; Tabori U; Schiffman J; Shlien A; Beyene J; Druker H; Novokmet A; Finlay J; Malkin D
    Lancet Oncol; 2011 Jun; 12(6):559-67. PubMed ID: 21601526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population.
    Gallardo-Alvarado LN; Tusié-Luna MT; Tussié-Luna MI; Díaz-Chávez J; Segura YX; Bargallo-Rocha E; Villarreal C; Herrera-Montalvo LA; Herrera-Medina EM; Cantu-de Leon DF
    BMC Cancer; 2019 Feb; 19(1):118. PubMed ID: 30709381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.